Publications by authors named "Didier Decaudin"

95Publications

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma.

Eur J Cancer 2020 02 9;126:93-103. Epub 2020 Jan 9.

Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.12.012DOI Listing
February 2020

Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.

Blood Adv 2019 10;3(20):2920-2933

Centre de Recherche des Cordeliers, Cell Death and Drug Resistance in Hematological Disorders Team, INSERM UMRS_1138, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849937PMC
October 2019

Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.

Ann Pharm Fr 2019 Nov 25;77(6):488-495. Epub 2019 Sep 25.

Laboratoire des biomolécules (LBM), CNRS - UMR 7203, Sorbonne université, École normale supérieure, PSL Research University, 75252 Paris cedex 05, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharma.2019.07.003DOI Listing
November 2019

Humanized Mice for the Study of Immuno-Oncology.

Trends Immunol 2018 09 2;39(9):748-763. Epub 2018 Aug 2.

INSERM U932, and SiRIC Translational Immunotherapy Team, Translational Research Department, Institut Curie, PSL Research University, Paris F-75005, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.it.2018.07.001DOI Listing
September 2018

Selumetinib-based therapy in uveal melanoma patient-derived xenografts.

Oncotarget 2018 Apr 24;9(31):21674-21686. Epub 2018 Apr 24.

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955168PMC
April 2018

Combinations of targeted therapies in human cancers.

Aging (Albany NY) 2016 10;8(10):2258-2259

Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.101085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115885PMC
October 2016

Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts.

Invest Ophthalmol Vis Sci 2016 Sep;57(11):4916-4926

Laboratory of Preclinical Investigation, Translational Research Department, Paris Sciences et Lettres (PSL) University, Institut Curie, Paris, France 8Department of Medical Oncology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.15-18725DOI Listing
September 2016

Uveal Melanoma Patient-Derived Xenografts.

Ocul Oncol Pathol 2015 Apr 9;1(3):161-9. Epub 2015 Apr 9.

Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000370154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847660PMC
April 2015

Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing.

Ocul Oncol Pathol 2015 Apr 9;1(3):200-6. Epub 2015 Apr 9.

Laboratory of Preclinical Investigation, Department of Translational Research, Paris, France; Department of Medical Oncology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000370156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847680PMC
April 2015

Enhanced serum proteolysis resistance of cell-penetrating peptides.

Ther Deliv 2015 Feb;6(2):139-47

CIMI-Paris, UPMC UMRS CR7-Inserm U1135-CNRS ERL 8255, Faculte de Medicine Pierre et Marie Curie, CHU Pitié Salpêtrière, 91, Bd de 1-Hôpital, 75013 Paris, France.

View Article

Download full-text PDF

Source
http://www.future-science.com/doi/10.4155/tde.14.100
Publisher Site
http://dx.doi.org/10.4155/tde.14.100DOI Listing
February 2015

Cell penetrating peptides as a therapeutic strategy in chronic lymphocytic leukemia.

Protein Pept Lett 2015 ;22(6):539-46

CIMI Paris, Universite Pierre et Marie Curie, 91 bd de l'hopital 75013 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929866522666150216115352DOI Listing
February 2016

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.

BMC Cancer 2014 Dec 4;14:916. Epub 2014 Dec 4.

Endocytic Trafficking and Therapeutic Delivery Group, UMR3666 CNRS - U1143 INSERM, Institut Curie-Centre de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289340PMC
December 2014

Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer.

Authors:
Didier Decaudin

Anticancer Drugs 2011 Oct;22(9):827-41

Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3283475f70DOI Listing
October 2011

Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit.

Mol Imaging 2011 Apr;10(2):135-43

Institut Langevin Ondes et Images, (CNRS UMR 7587), INSERM U979 Paris, France.

View Article

Download full-text PDF

Source
April 2011

Differential expression of the 18 kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer.

Mol Pharm 2011 Jun 4;8(3):823-32. Epub 2011 Apr 4.

Laboratoire d'Imagerie Moléculaire Expérimentale, Université Paris Sud , INSERM Unit 1023, 4 Place du Général Leclerc, F-91400 Orsay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/mp100433cDOI Listing
June 2011

(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Eur J Nucl Med Mol Imaging 2010 Jun 4;37(6):1095-105. Epub 2010 Mar 4.

Service de Médicine Nucléaire, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris 7, 1, avenue Claude Vellefaux, 75475, Paris cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-009-1377-5DOI Listing
June 2010

In vivo tumor targeting by the B-subunit of shiga toxin.

Mol Imaging 2008 Nov-Dec;7(6):239-47

Laboratoire d'Imagerie Moléculaire Expérimentale, Commissariat à l'Energie Atomique, Institut d'Imagerie Biomédicale, Orsay, France.

View Article

Download full-text PDF

Source
April 2009

Synthesis and properties of a mitochondrial peripheral benzodiazepine receptor conjugate.

ChemMedChem 2008 Nov;3(11):1687-95

Institut Curie, Centre de Recherche, Conception, Synthèse et Vectorisation de Biomolécules, 26 rue d'Ulm, 75248 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmdc.200800249DOI Listing
November 2008

Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphoma.

Anticancer Drugs 2008 Aug;19(7):673-80

Department of aClinical Hematology, Translational Research Department, Institut Curie, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3283043574DOI Listing
August 2008

Concurrent radiation therapy and bortezomib in myeloma patient.

Radiother Oncol 2008 Feb 15;86(2):290-2. Epub 2008 Jan 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2007.12.015DOI Listing
February 2008

Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody.

Anticancer Drugs 2007 Jul;18(6):725-31

Department of Clinical Haematology bUMR144 CNRS, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3280678042DOI Listing
July 2007

Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.

Anticancer Drugs 2007 Oct;18(9):1029-37

Laboratory of Pre-clinical Investigations, Institut National de la Santé et de la Recherche Médicale Unité 668, Institut Pasteur, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e3281e444cbDOI Listing
October 2007

Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug.

Angew Chem Int Ed Engl 2007 ;46(34):6469-72

UMR 176 CNRS, Institut Curie, Centre de Recherche, 26 rue d'Ulm 75248 Paris Cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.200701270DOI Listing
November 2007

Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.

Nat Med 2007 Jun 21;13(6):736-41. Epub 2007 May 21.

Institut Curie, Batiment 110, Centre Universitaire, 91405 Orsay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1588DOI Listing
June 2007

Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options.

Blood 2006 Sep 25;108(5):1451-60. Epub 2006 Apr 25.

Service d'Hématologie, Institut Curie, 26 rue d'Ulm, 75.248 Paris cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-02-005017DOI Listing
September 2006

PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor.

Oncogene 2005 Nov;24(51):7503-13

1Centre National de la Recherche Scientifique, UMR8125, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille-Desmoulins, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208907DOI Listing
November 2005

Peripheral benzodiazepine receptor and its clinical targeting.

Authors:
Didier Decaudin

Anticancer Drugs 2004 Sep;15(8):737-45

Department of Clinical Hematology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001813-200409000-00001DOI Listing
September 2004

Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.

Thromb Res 2002 Apr;106(2):127-30

Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, 75231 Paris Cedex 05, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0049-3848(02)00095-6DOI Listing
April 2002

Mantle cell lymphoma: a biological and therapeutic paradigm.

Authors:
Didier Decaudin

Leuk Lymphoma 2002 Apr;43(4):773-81

Department of Hematology, Service d'Hématologie, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819029001688
Publisher Site
http://dx.doi.org/10.1080/10428190290016881DOI Listing
April 2002

Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.

Cancer Res 2002 Mar;62(5):1388-93

Department of Hematology, and UMR 147 CNRS, Section de Recherche, Institut Curie, 75005 Paris, France.

View Article

Download full-text PDF

Source
March 2002